Results 81 to 90 of about 10,035 (161)

Biopharmaceutics

Journal of Pharmacy and Pharmacology, 2007
openaire   +1 more source

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025. [PDF]

CPT Pharmacometrics Syst Pharmacol
Cordes H, Annaert P, Balazki P, Benamara S, Bonan RH, Butler A, Chenel M, Cui Y, Dallmann A, de Witte WEA, Demeester C, Feick D, Gattacceca F, Geci R, Gerebtzoff G, Gruber A, Guimarães M, Hamadeh A, Hanke N, Ibarra M, Ince I, Kanacher T, Kuepfer L, Mil F, Montaseri G, Nauwelaerts N, Proenca S, Schaller S, Schlender JF, Schneider ARP, Sjögren E, Solodenko J, Staab A, Vrenken P, Troisi C, Teutonico D.   +35 more
europepmc   +1 more source

Dataset of xenobiotics human renal clearance values. [PDF]

Database (Oxford)
Łapińska N, Polak S.
europepmc   +1 more source

DoE- and PBBM-Driven Formulation Development of an Extended-Release Donepezil Tablet. [PDF]

Pharmaceuticals (Basel)
Martins FS, Borges LL, Kollipara S, Sivadasu P, Couto ROD.   +4 more
europepmc   +1 more source

Correction: Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma. [PDF]

Front Med (Lausanne)
Frontiers Production Office.
europepmc   +1 more source

Biopharmaceutics [PDF]

, 2020
openaire   +1 more source

Corrigendum to "Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo" [Eur. J. Pharm. Biopharm. 117 (2017) 400-407].

Eur J Pharm Biopharm
Vicente-Perez EM, Larrañeta E, McCrudden MTC, Kissenpfennig A, Hegarty S, McCarthy HO, Donnelly RF.   +6 more
europepmc   +1 more source

Virtual Bioequivalence Assessment and Dissolution Safe Space Exploration for Fixed-Dose Metformin-Glyburide Tablet Using Physiologically Based Biopharmaceutics Modeling. [PDF]

Pharmaceutics
Zhao C, Shen C, Xiao Y, Wang L.
europepmc   +1 more source

Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP). [PDF]

J Pharm Sci
Perazzolo S, Shen DD, Ho RJY.
europepmc   +1 more source

Editorial: Immune checkpoints regulatory mechanisms and immunotherapy strategies in gastrointestinal tumors. [PDF]

Front Oncol
Xi Q, Zhang R.
europepmc   +1 more source